Social Behavior – Page 14

Leqembi’s Global Sales Reach $67 Million, Yet US Adoption Faces Hurdles

11 months ago talkbio0Tagged Adoption, Alzheimer 's disease, Biogen, Eisai, global sales, Leqembi, U.S.

Leqembi, Biogen, Eisai, Alzheimer’s disease, global sales, US adoption challenges

GSK Shifts Focus from Acquired Vaccine to Preclinical Successor Due to Increased Competition

11 months ago talkbio0Tagged Affinivax, competition, Increased, MAPS technology, Pneumococcal vaccine, Preclinical Successor, SmithKline Beecham, Vaccines

GSK, vaccine, preclinical successor, increased competition, pneumococcal vaccine, Affinivax, MAPS technology

Novartis and Monte Rosa Collaborate on $2.2B Molecular Glue Degrader Alliance

11 months ago talkbio0Tagged Biopharma, Collaboration, molecular glue, Monte Rosa, Neoplasms, Neurological diseases, Novartis, Protein Degradation, Metabolic

Novartis, Monte Rosa, molecular glue degraders, biopharma collaboration, protein degradation, oncology, neurological diseases

Novartis Invests $150M in Monte Rosa’s Molecular Glue Technology for Autoimmune Diseases

11 months ago talkbio0Tagged Autoimmune Diseases, biotech, Collaboration, molecular glue, Monte Rosa, Novartis, Protein Degradation, Metabolic, VAV1-degrader

Novartis, Monte Rosa, Molecular Glue, Protein Degradation, Autoimmune Diseases, MRT-6160, VAV1-degrader, Biotech Collaboration

Roche and Dyno Therapeutics Launch $1B+ Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Neurological Diseases

11 months ago talkbio0Tagged AAVS1 gene, Cloning Vectors, Collaboration, Dyno, gene delivery process, gene therapy, LEAP, Neurological diseases, Roche (company), Technology

Roche, Dyno Therapeutics, AAV gene therapy vectors, Neurological diseases, AI-driven gene delivery, LEAP technology, Gene therapy collaboration

WuXi AppTec and WuXi Biologics Consider Asset Sales Amid BIOSECURE Act Scrutiny

11 months ago talkbio0Tagged AppTec, asset, Biological Factors, BIOSECURE, Industry, Relations, Sales - occupational activity, U.S.-China, WuXi

WuXi AppTec, WuXi Biologics, BIOSECURE Act, asset sales, biotech industry, US-China relations

Turnstone Biologics Undergoes Strategic Restructuring with Layoffs and Leadership Changes

11 months ago talkbio0Tagged Arenaria, Biological Factors, Changing, Industry, Leadership, restructuring, strategic

Turnstone Biologics, layoffs, leadership changes, strategic restructuring, biotech industry

Teva Pharmaceuticals Agrees to $450M Settlement Over Kickback and Price-Fixing Allegations

11 months ago talkbio0Tagged Copaxone, False, Kickbacks, Medicare, Price Fixing, Settlement and Resettlement, Teva Pharmaceuticals

Teva Pharmaceuticals, False Claims Act, Anti-Kickback Statute, price-fixing, kickbacks, settlement, generic drugs, Medicare, Copaxone

Glooko Secures $100 Million Funding to Enhance Diabetes Management Platform Under New Leadership

11 months ago talkbio0Tagged Administration occupational activities, Diabetes, Glooko, Healthcare technology, Leadership

Glooko, diabetes management, healthcare technology, funding, new leadership

Eli Lilly and Insitro Collaborate on AI-Driven Therapies for Metabolic Diseases

11 months ago talkbio0Tagged Agreement, Antibody Therapy, Aortic Valve Insufficiency, Artificial Intelligence, Drug Development, Eli, Eli Lilly, Insitro, MASLD, Metabolic, Metabolic Diseases, RNA, Small Interfering, steatotic liver disease, strategic

Eli Lilly, Insitro, AI, Metabolic Diseases, Drug Development, Strategic Agreements, siRNA Therapies, Antibody Therapy, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)